...
首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >A REVIEW ON RESEALED ERYTHROCYTE AS A NOVEL DRUG DELIVERY SYSTEM
【24h】

A REVIEW ON RESEALED ERYTHROCYTE AS A NOVEL DRUG DELIVERY SYSTEM

机译:新型红血球输送系统对重新获得的红细胞的评价

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Cellular carriers possess great potential and merits in various modules of drug delivery. Among such cellular carriers, erythrocytes have been found to possess huge merits for the targeted and controlled drug delivery since they are non-immunogenic, non-toxic and their circulation can be readily controlled and could be manipulated with reference to time. Erythrocytes mediated drug delivery has been reported with therapeutic enzymes and antiviral agents to maximize therapeutic performance, reduce the side effects, as circulating depots for controlled drug release, drug targeting, treatment of parasitic diseases, hepatic tumors, removal of toxic agents etc. In this review, isolation of carrier erythrocytes, methods of drug loading, characterization parameters methods and clinical applications of resealed erythrocytes were presented.
机译:细胞载体在药物递送的各种模块中具有巨大的潜力和优点。在这样的细胞载体中,由于红细胞是非免疫原性的,无毒的并且它们的循环可以容易地控制并且可以参考时间进行操纵,因此已经发现其具有针对靶向和受控药物递送的巨大优点。据报道,红血球介导的治疗性酶和抗病毒剂可最大程度地发挥治疗作用,减少副作用,例如用于控制药物释放,靶向药物,治疗寄生虫病,肝肿瘤,清除有毒物质的循环库等。介绍了载体红细胞的分离,分离,载药方法,表征参数方法以及重新密封的红细胞的临床应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号